Ambulatory Hypertension Subtypes and 24-Hour Systolic and Diastolic Blood Pressure as Distinct Outcome Predictors in 8341 Untreated People Recruited From 12 Populations

Research output: Contribution to journalJournal articleResearchpeer-review

  • Yan Li
  • Fang-Fei Wei
  • Lutgarde Thijs
  • José Boggia
  • Kei Asayama
  • Tine W Hansen
  • Masahiro Kikuya
  • Kristina Björklund-Bodegård
  • Takayoshi Ohkubo
  • Jørgen Jeppesen
  • Yu-Mei Gu
  • Christian Torp-Pedersen
  • Eamon Dolan
  • Yan-Ping Liu
  • Tatiana Kuznetsova
  • Katarzyna Stolarz-Skrzypek
  • Valérie Tikhonoff
  • Sofia Malyutina
  • Edoardo Casiglia
  • Yuri Nikitin
  • Lars Lind
  • Edgardo Sandoya
  • Kalina Kawecka-Jaszcz
  • Luis Mena
  • Gladys E Maestre
  • Jan Filipovský
  • Yutaka Imai
  • Eoin O'Brien
  • Ji-Guang Wang
  • Jan A Staessen
  • International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators

BACKGROUND: Data on risk associated with 24-hour ambulatory diastolic (DBP24) versus systolic (SBP24) blood pressure are scarce.

METHODS AND RESULTS: We recorded 24-hour blood pressure and health outcomes in 8341 untreated people (mean age, 50.8 years; 46.6% women) randomly recruited from 12 populations. We computed hazard ratios (HRs) using multivariable-adjusted Cox regression. Over 11.2 years (median), 927 (11.1%) participants died, 356 (4.3%) from cardiovascular causes, and 744 (8.9%) experienced a fatal or nonfatal cardiovascular event. Isolated diastolic hypertension (DBP24≥80 mm Hg) did not increase the risk of total mortality, cardiovascular mortality, or stroke (HRs≤1.54; P≥0.18), but was associated with a higher risk of fatal combined with nonfatal cardiovascular, cardiac, or coronary events (HRs≥1.75; P≤0.0054). Isolated systolic hypertension (SBP24≥130 mm Hg) and mixed diastolic plus systolic hypertension were associated with increased risks of all aforementioned end points (P≤0.0012). Below age 50, DBP24 was the main driver of risk, reaching significance for total (HR for 1-SD increase, 2.05; P=0.0039) and cardiovascular mortality (HR, 4.07; P=0.0032) and for all cardiovascular end points combined (HR, 1.74; P=0.039) with a nonsignificant contribution of SBP24 (HR≤0.92; P≥0.068); above age 50, SBP24 predicted all end points (HR≥1.19; P≤0.0002) with a nonsignificant contribution of DBP24 (0.96≤HR≤1.14; P≥0.10). The interactions of age with SBP24 and DBP24 were significant for all cardiovascular and coronary events (P≤0.043).

CONCLUSIONS: The risks conferred by DBP24 and SBP24 are age dependent. DBP24 and isolated diastolic hypertension drive coronary complications below age 50, whereas above age 50 SBP24 and isolated systolic and mixed hypertension are the predominant risk factors.

Original languageEnglish
JournalCirculation
Volume130
Issue number6
Pages (from-to)466-474
Number of pages9
ISSN0009-7322
DOIs
Publication statusPublished - 5 Aug 2014

    Research areas

  • Adolescent, Adult, Aged, Aged, 80 and over, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Cohort Studies, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged, Population Surveillance, Predictive Value of Tests, Treatment Outcome, Young Adult

ID: 138270828